UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice

Neuropharmacology, 2013-02, Vol.65, p.29-38

2013

Volltextzugriff (PDF)

The Selective Metabotropic Glutamate 2/3 Receptor Agonist MGS0028 Reverses Isolation Rearing–Induced Abnormal Behaviors in Mice

Journal of Pharmacological Sciences, 2012, Vol.118(2), pp.295-298

2012

Volltextzugriff (PDF)

Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands

Bioorganic & medicinal chemistry, 2004-01, Vol.12 (2), p.423-438

2004

Volltextzugriff (PDF)

Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice

Neuropharmacology, 2011-02, Vol.60 (2-3), p.397-404

2011

Volltextzugriff (PDF)

Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450

European journal of pharmacology, 2004-02, Vol.485 (1-3), p.145-158

2004

Volltextzugriff (PDF)

The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptide

Behavioural pharmacology, 2013-02, Vol.24 (1), p.74

2013

Volltextzugriff (PDF)

Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission

Psychopharmacologia, 2011-10, Vol.217 (3), p.443-452

2011

Volltextzugriff (PDF)

Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor

The Journal of pharmacology and experimental therapeutics, 2003-02, Vol.304 (2), p.818

2003

Volltextzugriff (PDF)

Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors

Neuroscience letters, 2005-04, Vol.378 (3), p.131-134

2005

Volltextzugriff (PDF)

Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor Agonists

Journal of medicinal chemistry, 2000-12, Vol.43 (25), p.4893-4909

2000

Volltextzugriff (PDF)

Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001

The Journal of pharmacology and experimental therapeutics, 1999-05, Vol.289 (2), p.926

1999

Volltextzugriff (PDF)

Synthesis, in Vitro Pharmacology, Structure−Activity Relationships, and Pharmacokinetics of 3-Alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent and Selective Group II Metabotropic Glutamate Receptor Antagonists

Journal of medicinal chemistry, 2004-08, Vol.47 (18), p.4570-4587

2004

Volltextzugriff (PDF)

Design, synthesis, and structure–activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands

Bioorganic & medicinal chemistry, 2004-07, Vol.12 (13), p.3569-3580

2004

Volltextzugriff (PDF)

Structure–activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor

Bioorganic & medicinal chemistry, 2007-03, Vol.15 (5), p.1989-2005

2007

Volltextzugriff (PDF)

Identification of Arginine Analogues as Antagonists and Agonists for the Melanocortin-4 Receptor

Chemical and Pharmaceutical Bulletin, 2007/08/01, Vol.55(8), pp.1232-1239

2007

Volltextzugriff (PDF)

In vitro and in vivo evaluation of the metabolism and bioavailability of ester prodrugs of mgs0039 (3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid), a potent metabotropic glutamate receptor antagonist

Drug metabolism and disposition, 2006-03, Vol.34 (3), p.369

2006

Volltextzugriff (PDF)

Binding characteristics of [formula omitted]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors

European journal of pharmacology, 1999-04, Vol.371 (2), p.197-204

1999

Volltextzugriff (PDF)

Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106

Life sciences (1973), 1999-03, Vol.64 (16), p.1455-1464

1999

Volltextzugriff (PDF)

Synthesis, in vitro pharmacology, and pharmacokinetic profiles of 2-[1-amino-1-carboxy-2-(9 H-xanthen-9-yl)-ethyl]-1-fluorocyclopropanecarboxylic acid and its 6-heptyl ester, a potent mGluR2 antagonist

Bioorganic & medicinal chemistry, 2008-04, Vol.16 (8), p.4359-4366

2008

Volltextzugriff (PDF)

Synthesis of Diphenylmethyl Analogues and Their Affinity for the Melanocortin-4 Receptor and the Serotonin Transporter

Chemical and Pharmaceutical Bulletin, 2007, Vol.55(7), pp.1044-1050

2007

Volltextzugriff (PDF)

Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding

FEBS letters, 1999-02, Vol.445 (1), p.19-22

1999

Volltextzugriff (PDF)

Metabolism and disposition of a potent group II metabotropic glutamate receptor agonist, in rats, dogs, and monkeys

Drug metabolism and disposition, 2005-09, Vol.33 (9), p.1373

2005

Volltextzugriff (PDF)

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity

Neuropharmacology, 2004-03, Vol.46 (4), p.457-467

2004

Volltextzugriff (PDF)

In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001

European journal of pharmacology, 1999-04, Vol.371 (2-3), p.205-211

1999

Volltextzugriff (PDF)

Increase of 20-HETE Synthase after Brain Ischemia in Rats Revealed by PET Study with 11 C-Labeled 20-HETE Synthase-Specific Inhibitor

Journal of cerebral blood flow and metabolism, 2012-09, Vol.32 (9), p.1737-1746

2012

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(116)
Buchkapitel
(1)

Sprache

Englisch
(103)
Japanisch
(45)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Animals
(46)
Pharmacology & Pharmacy
(44)
Male
(40)
Rats
(32)
Biological And Medical Sciences
(29)
Medical Sciences
(27)
Pharmacology. Drug Treatments
(27)
Neuropharmacology
(23)
Rats, Wistar
(20)
Chemistry, Medicinal
(18)
Structure-Activity Relationship
(16)
Neurotransmitters. Neurotransmission. Receptors
(15)
Mice
(14)
Chemistry
(13)
Depression
(12)
Physical Sciences
(12)
Neurosciences
(11)
Neurosciences & Neurology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice

The Selective Metabotropic Glutamate 2/3 Receptor Agonist MGS0028 Reverses Isolation Rearing–Induced Abnormal Behaviors in Mice

Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands

Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice

Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450

The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptide

Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission

Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor

Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors

Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor Agonists

Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001

Synthesis, in Vitro Pharmacology, Structure−Activity Relationships, and Pharmacokinetics of 3-Alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent and Selective Group II Metabotropic Glutamate Receptor Antagonists

Design, synthesis, and structure–activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands

Structure–activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor

Identification of Arginine Analogues as Antagonists and Agonists for the Melanocortin-4 Receptor

In vitro and in vivo evaluation of the metabolism and bioavailability of ester prodrugs of mgs0039 (3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid), a potent metabotropic glutamate receptor antagonist

Binding characteristics of [formula omitted]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors

Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106

Synthesis, in vitro pharmacology, and pharmacokinetic profiles of 2-[1-amino-1-carboxy-2-(9 H-xanthen-9-yl)-ethyl]-1-fluorocyclopropanecarboxylic acid and its 6-heptyl ester, a potent mGluR2 antagonist

Synthesis of Diphenylmethyl Analogues and Their Affinity for the Melanocortin-4 Receptor and the Serotonin Transporter

Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding

Metabolism and disposition of a potent group II metabotropic glutamate receptor agonist, in rats, dogs, and monkeys

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity

In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001

Increase of 20-HETE Synthase after Brain Ischemia in Rats Revealed by PET Study with 11 C-Labeled 20-HETE Synthase-Specific Inhibitor

Suchergebnisse filtern